Trial Profile
Proof of Concept Study in Male and Female Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Solnatide (Primary)
- Indications Acute lung injury; Pulmonary oedema
- Focus Proof of concept; Therapeutic Use
- Sponsors APEPTICO Forschung und Entwicklung
- 28 Aug 2014 According to the European Clinical Trials Database record, status changed from active, no longer recruiting to completed.
- 23 Aug 2014 New source identified and integrated (European Clinical Trials Database record: EudraCT2012-001863-64)
- 09 Apr 2014 Topline results were reported in an Apeptico media release.